Krystal Biotech Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $593.6M | $341.2M |
| FY2022 | — | $522.2M | $161.9M |
| FY2023 | — | $778.6M | $358.3M |
| FY2024 | — | $946.4M | $344.9M |
| FY2025 | — | $1.22B | $496.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $593.6M | $341.2M |
| FY2022 | — | $522.2M | $161.9M |
| FY2023 | — | $778.6M | $358.3M |
| FY2024 | — | $946.4M | $344.9M |
| FY2025 | — | $1.22B | $496.3M |